¼º±Õ°üÀÇ´ë ÃÖµÎÈ£ ±³¼ö, ¹æ»ç¼±Á¾¾çÇÐȸ ÃÖ¿ì¼ö³í¹®»ó ¼ö»ó

´º½ºÀÏÀÚ: 2009³â05¿ù12ÀÏ 00½Ã00ºÐ

¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú ÃÖµÎÈ£ ±³¼ö°¡ Áö³­ 8ÀÏ ´ë±¸ ÀÎÅͺҰíÈ£ÅÚ¿¡¼­ °³ÃÖµÈ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ¿¡¼­ ‘ÀþÀº Çѱ¹ÀÎ À¯¹æ¾Ï ȯÀÚ¿¡¼­ BRCA1/2 µ¹¿¬º¯ÀÌ¿Í È£¸£¸ó ¼ö¿ëü, HER-2 »óÅ¿¡ °üÇÑ ¿¬±¸’¶ó´Â ÁÖÁ¦ÀÇ ³í¹®À¸·Î 2008³âµµ ÃÖ¿ì¼ö ³í¹®»óÀ» ¼ö»óÇß´Ù.

 


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.